Article
The effects of genomic polymorphisms in one-carbon metabolism pathways on survival of gastric cancer patients received fluorouracil-based adjuvant therapy.
Scientific reports - 26 Jul 2016
Zhao Tingting, Xu Zhi, Gu Dongying, Wu Peng, Huo Xinying, Wei Xiaowei, Tang Yongfei, Gong Weida, He Ming-Liang, Chen Jinfei
Abstract excerpt
5-fluorouracil (5-FU) is widely used to treat patients with gastric cancer (GC). However, the response rate is quite heterogeneous. The single nucleotide polymorphisms (SNPs) and their interactions of genes in the one-carbon metabolism (OCM) pathway, including Methylenetetrahydrofolate reductase (MTHFR), Methionine synthase reductase (MTRR), Methionine synthase (MTR), and Thymidylate synthase (TS), significantly...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
